[
  {
    "ts": null,
    "headline": "WST Launches Synchrony S1 Prefillable Syringe at Pharmapack",
    "summary": "West Pharmaceutical debuts the Synchrony S1 prefillable syringe at Pharmapack 2026, enhancing biologics, vaccines and home-care support.",
    "url": "https://finnhub.io/api/news?id=329f9b58b31efb10618c3ad2944a5bec5b43f29e924b2ae6bd770fb9c952e437",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769194200,
      "headline": "WST Launches Synchrony S1 Prefillable Syringe at Pharmapack",
      "id": 138229446,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "West Pharmaceutical debuts the Synchrony S1 prefillable syringe at Pharmapack 2026, enhancing biologics, vaccines and home-care support.",
      "url": "https://finnhub.io/api/news?id=329f9b58b31efb10618c3ad2944a5bec5b43f29e924b2ae6bd770fb9c952e437"
    }
  },
  {
    "ts": null,
    "headline": "Danaher Gears Up to Post Q4 Earnings: What Lies Ahead for the Stock?",
    "summary": "DHR is set to report Q4 results on Jan. 28, with revenues seen up 3.9% and bioprocessing and diagnostics strength in focus.",
    "url": "https://finnhub.io/api/news?id=015ef82ae6a5731f64c42bb00406740b2e7c4c218476d1e027f01fa256f17d6d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769176080,
      "headline": "Danaher Gears Up to Post Q4 Earnings: What Lies Ahead for the Stock?",
      "id": 138225733,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "DHR is set to report Q4 results on Jan. 28, with revenues seen up 3.9% and bioprocessing and diagnostics strength in focus.",
      "url": "https://finnhub.io/api/news?id=015ef82ae6a5731f64c42bb00406740b2e7c4c218476d1e027f01fa256f17d6d"
    }
  },
  {
    "ts": null,
    "headline": "Can Specialty Diagnostics Strength Drive Thermo Fisher's Q4 Earnings?",
    "summary": "TMO heads into Q4 earnings with Specialty Diagnostics growth, fresh FDA approvals and launches that could lift results on Jan. 29.",
    "url": "https://finnhub.io/api/news?id=ac755a74b98ca9bd6d2503866d0b5e23713dd9aee1a03cc3b56a1a81fa8e3c28",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769170620,
      "headline": "Can Specialty Diagnostics Strength Drive Thermo Fisher's Q4 Earnings?",
      "id": 138224810,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "TMO heads into Q4 earnings with Specialty Diagnostics growth, fresh FDA approvals and launches that could lift results on Jan. 29.",
      "url": "https://finnhub.io/api/news?id=ac755a74b98ca9bd6d2503866d0b5e23713dd9aee1a03cc3b56a1a81fa8e3c28"
    }
  },
  {
    "ts": null,
    "headline": "Cardinal Health Upgraded As It Maintains Investment-Grade Status And Position In Radiopharmaceuticals",
    "summary": "Cardinal Health (CAH) upgraded to Buy after a 100%+ runâsee FY26 guidance, acquisitions, and nuclear medicine catalysts, plus key risks.",
    "url": "https://finnhub.io/api/news?id=c097a7d0b3ac6d9f8a470f1eb6225a68fd0af8f696df7ec78a311a4bd82fe253",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769159695,
      "headline": "Cardinal Health Upgraded As It Maintains Investment-Grade Status And Position In Radiopharmaceuticals",
      "id": 138225134,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1353669780/image_1353669780.jpg?io=getty-c-w1536",
      "related": "CAH",
      "source": "SeekingAlpha",
      "summary": "Cardinal Health (CAH) upgraded to Buy after a 100%+ runâsee FY26 guidance, acquisitions, and nuclear medicine catalysts, plus key risks.",
      "url": "https://finnhub.io/api/news?id=c097a7d0b3ac6d9f8a470f1eb6225a68fd0af8f696df7ec78a311a4bd82fe253"
    }
  },
  {
    "ts": null,
    "headline": "Zacks Industry Outlook Highlights McKesson, Cardinal Health, West Pharmaceutical and Align Technology",
    "summary": "McKesson, Cardinal Health, West Pharmaceutical, and Align Technology are set to benefit from innovation, aging populations, and rising medical supply demand in 2026.",
    "url": "https://finnhub.io/api/news?id=67b1272fc019ccf7e80287801b50aeaf77caefd54db11d5d8bdf4f44e6d3fe08",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769158680,
      "headline": "Zacks Industry Outlook Highlights McKesson, Cardinal Health, West Pharmaceutical and Align Technology",
      "id": 138223486,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "McKesson, Cardinal Health, West Pharmaceutical, and Align Technology are set to benefit from innovation, aging populations, and rising medical supply demand in 2026.",
      "url": "https://finnhub.io/api/news?id=67b1272fc019ccf7e80287801b50aeaf77caefd54db11d5d8bdf4f44e6d3fe08"
    }
  }
]